Drug Updates

Drug updates provide the latest information and relevant warnings and notifications.

Update on Drugs and Drug News: November-December 2015

Update on Polidocanol 1% injectable foam (Varithena®), Cobimetinib + vemurafenib (Cotellic™ + Zelboraf®), Adalimumab SC injection (Humira®), Hyaluronic acid filler (Juvederm® Ultra XC), Nivolumab + ipilimumab (Opdivo® + Yervoy®), Ingenol mebutate gel (Picato®)

Update on Drugs and Drug News: October 2002

Updates on: Ketoconazole Ketoderm® Cream 2% Benzoyl Peroxide, Clindamycin DUAC® Topical Gel Trans-Ver-Sal® Wart Removal Patch Rubitecan Orathecin™ Loratidine Claritin® 10mg Tablets

Update on Drugs and Drug News: February, 2000

Update on: Aminolevulinic Acid Levulan Photodynamic Therapy G-3139 Genta Inc Moxifloxacin HCl Avelox Ciclopirox Loprox 8% Topical Solution 5-fluorouracil Solex Allovectin-7 Vical Inc

Update on Drugs and Drug News: May 2012

Update on drugs, approval dates, and comments. Belimumab Adapalene (0.3% gel Differin®), Vemurafenib tablet (Zelboraf®), Wound care spray (Granulox®), as well as devices like the laser device for onychomycosis Harmony® XL are covered.

Update on Drugs & Devices: January-February 2022

Drug update covering: Adalimumab-adbm for SC use - Cyltezo®, Tralokinumab for SC use - Adtralza® (in Canada), Tralokinumab-ldrm for SC use - Adbry™ (in US), Melanoma vaccine for IV use - BNT111, Adalimumab-aqvh for SC use - Yusimry™, and more...

Update on Drugs & Devices: July – August 2018

Update on Dabrafenib + trametinib in combination (Tafinlar®+Mekinist®), Certolizumab pegol for SC injection (Cimzia®), Ubidecarenone injectable nanosuspension (BPM 31510), Diacerein 1% ointment (CCP-020), Ixekizumab for SC injection (Taltz®), Hyaluronic acid (HA) dermal filler (Restylane® Lyft®), and Rituximab for IV use (Rituxan®).

Update on Drugs & Devices: May – June 2020

Update on Selumetinib capsules (Koselugo®), Crisaborole 2% ointment (Eucrisa®), Infliximab biosimilar for IV injection (Avsola™) and Baricitinib tablets (Olumiant®)

Update on Drugs and Drug News: May-June 2013

Update on Acyclovir 50 mg buccal tablets (Sitavig®), Acyclovir 5% + hydrocortisone 1% cream (Xerese®), Botulinum toxin type A for injection (Dysport®), Desoximetasone 0.25% topical spray (Topicort®), Carbinoxamine maleate extendedrelease oral suspension (Karbinal™ ER), and C1-esterase inhibitor (Berinert®)

Update on Drugs & Devices: May-June 2022

This update covers Nivolumab + Relatlimab-rmbw for IV use - Opdualag™ (Bristol-Myers Squibb), Sirolimus topical gel 0.2% - Hyftor™ (Nobelpharma America), Oral epinephrine - AQST-109 (Aquestive Therapeutics), and Bimekizumab for SC use - Bimzelx® (UCB Canada Inc.).

Update on Drugs and Drug News: January-February 2014

Update on Hyaluronic acid gel dermal filler (Juvéderm Voluma™XC), Methotrexate injection (Otrexup™), Luliconazole 1% cream (Luzu®), Smallpox vaccine (Imvamune®)

Update on Drugs and Drug News: July-August 2017

This drug update covers Infliximab-abda for IV infusion Renflexis®, Ozenoxacin 1% cream Ozanex™, Standardized allergen extract of house dust mites sublingual tablet Acarizax®, Doxycycline hyclate immediate release tablet, and UVB Phototherapy SystemClarify™ Home Light Therapy System.

Update on Drugs & Devices: May-June 2018

Update on Drugs & Devices May and June 2018: Tildrakizumab-asmn for SC injection Ilumya™, Lidocaine topical system 1.8% for postherpetic neuralgia ZTlido™, Secukinumab for SC injection Cosentyx®, Vaginal gel for prevention of urogenital chlamydia Amphora®.

Update on Drugs and Drug News: September 2009

Update on Collagen-based dermal filler Evolence®, Injectable Poly-L-lactic acid Sculptra Aesthetic®, Ibritumomab tiuxetan Zevalin®, and news from US FDA on TNF blockers.

Update on Drugs and Drug News – February 2008

Update on Anti-psoriatic Agent Ustekinumab CNTO 1275, Anti-arthritic Agent Tocilizumab Actemra®, Neurotoxin Botulinum Toxin Type A Reloxin®, and news from The National Institute for Health and Clinical Excellence (NICE) in the UK.

Update on Drugs and Drug News: January, 1998

Update on: Norgestimate / Ethinylestradiol Tri-Cyclen® Lidocaine/Prilocaine Cream Emla®Tretinoin gel 0.025% Avita® Adapalene solution 0.1% Differin®Topical tissue adhesive Dermabond® Atorvastin calcium Lipitor® Isotretinoin Accutane®

Update on Drugs & Drug News, November 2005

Updates on: Desloratadine CLARINEX® REDITABS® Dapsone ACZONE™ Gel 5% Metronidazole Metrogel® Topical Gel 1% Measles, Mumps, Rubella and Varicella Vaccine Proquad®

Update on Drugs and Drug News: May 2002

Update on: Alefacept AMEVIVE®Sodium Hyaluronate LAM IPM Wound Gel® Hydroquinone, Tretinoin, Fluocinolone Acetonide Tri-Luma® Cream Loratidine Claritin®

Update on Drugs and Drug News: September-October 2016

This update covers Pembrolizumab IV injection (Keytruda®), Hyaluronic acid gel filler (Juvéderm Volbella® XC), Biosimilar of infliximab (Flixabi®), Ceftaroline fosamil for IV infusion (Teflaro®), Dermal filler with calcium hydroxylapatite (CaHA) + integral 0.3% lidocaine (Radiesse® + Lidocaine), Ixekizumab SC injection (Talz®), Adapalene gel 0.1% (Differin® Gel), C1 esterase inhibitor(human) for IV infusion (Berinert®)

Update on Drugs and Drug News: July – August 2009

Update on Benzyl Alcohol Lotion 5% Sciele Pharma, Red Light Technology Device + Methyl Aminolevulinate Cream Aktilite® CL 128 + Metvix®, and news Nexavar®.

Update on Drugs and Drug News – May 2006

Update on Fluocinonide VANOS™ 0.1% Cream, Infliximab Remicade®, Tigecycline TYGACIL®, as well as drug warnings and industry news.

Update on Drugs and Drug News: March 2002

Updates on: Naturally-Derived Alpha Interferon Efavirenz Sustiva®Estradiol/Levonorgestrel Alesse®HSPPC-96 Oncophage®Tenofovir Disoproxil Fumerate Viread® Desloratidine Clarinex® 5mg. Tablets

Update on Drugs and Drug News – July-August 2006

Update on Zoster Vaccine Live Zostavax®, Doxycycline, 40mg Oracea®, Hyaluronic Acid Dermal Filler Juvéderm® Gel, Mycophenolate Mofetil CellCept®, Suberoylanilide Hydroxamic Acid (SAHA) Zolinza®, Quadrivalent Human Papillomavirus Recombinant Vaccine Gardasil®, and Adalimumab Humira®.

Update on Drugs and Drug News: January-February 2016

January and February 2016: Update on drugs, approval dates, and comments. Autologous cell suspension (ReCell® ReGenerCell® ReNovaCell®), Calcipotriene 0.005% + betamethasone dipropionate 0.064% foam (Enstilar®), Ipilimumab (Yervoy®), Talimogene laherparepvec (T-Vec) oncolytic virus therapy (Imlygic™), Cobimetinib + vemurafenib (Cotellic™ + Zelboraf®), Dabrafenib + trametinib (Tafinlar® + Mekinist®), Nivolumab injection (Opdivo®) are covered.

Update on Drugs and Drug News: April 2011

Update on drugs, approval dates, and comments. Gabapentin tablets GRALISE™(DM-1796), Oxychlorine compound (Epicyn™ HydroGel), Collagenase clostridium histolyticum (XIAPEX®) as well as drug news on HPV vaccines.

Update on Drugs and Drugs News April 2005

Updates on: Clinical Phototherapy System ClearTouch™ Light Unit Assembly Adalimumab HUMIRA® Dalbavancin Vicuron MDX-010 Medarex Clindamycin Evoclin® Foam 1%

Update on Drugs and Drug News: January 2011

Update on drugs, approval dates, and comments. Calcipotriene/Calcipotriol0.005% foam (Sorilux™), Ceftaroline fosamil (Teflaro™) are covered as well as an update on Health Canada on the use of tacrolimus (Protopic®) for atopic dermatitis.

Update on Drugs & Devices: September – October 2018

Updates on Binimetinib + Encorafenib (Mektovi® + Braftovi®), Crisaborole 2% ointment (Eucrisa™), Glycopyrronium tosylate 2.4% cloth (Qbrexza™), Secukinumab for SC injection (Consentyx®), Tecovirimat capsule (Tpoxx), Diacerein 1% ointment (CCP-020), Migalastat capsule (Galafold™), Mogamulizumabkpkc for IV use (Poteligeo®)

Update on Drugs and Drug News: May, 1999

Update on: Alendronate Fosamax Alitretinoin Panretin Gel 0.1% Malathion Ovide 0.5% Lotion Abacavir Sulfate Ziagen Interferon alpha-2a Roferon-A Lidocaine Patch 5% Lidoderm Pexiganan acetate Locilex cream 1% Aminolevulinic acid Levulan Photodynamic Therapy Ketoconazol Teva Antiviral Agents Antirejection Therapy

Update on Drugs and Drug News: April 2010

Update on drugs, approval dates, and comments. Collagenase clostridium histolyticum (XIAFLEX™), HPV quadrivalent recombinant vaccine (Gardasil®), Velaglucerase alfa (VPRIV™), Agalsidase alfa (REPLAGAL®), Adalimumab (Humira®) are covered.

Update on Drugs and Drug News: September 2010

Update on drugs, approval dates, and comments. Velaglucerase alfa (VPRIV®) and Health Canada labelling changes for isopropyl myristate 50% rinse (Resultz®, Nycomed) to include the treatment of lice in children =2 years of age are covered.

Update on Drugs and Drug News: January-February 2015

Update on Apremilast tablets (Otezla®), Collagenase clostridium histolyticum for injection (Xiaflex®), Afamelanotide 16 mg subcutaneous bioresorbable implants (Scenesse®), Clindamycin phosphate 1.2% + benzoyl peroxide 3.75% gel (Onexton™), Dupilumab SC injection, Apremilast tablets (Otezla®).

Update on Drugs and Drug News: May 2011

Update on drugs, approval dates, and comments. Belimumab (Benlysta®), Ipilimumab (Yervoy™), Imiquimod 3.75% Cream (Vyloma™) are covered.

Update on Drugs and Drug News: Number 3 2000

Updates on: 5-fluorouracil 5-FU Microsponge Interferon-Alpha Veldona Hydroxyurea Amprenavir Agenerase Diclofenac Sodium Solaraze

Update on Drugs and Drugs News May 2005

Updates on: Fluocinonide 0.1% Cream Vanos™ Dalvancin Epinastine Hydrochloride Alesion® Dry Syrup 1% Griseofulvin Oral Suspension USP

Update on Drugs and Drug News: May, 2000

Update on: Bexarotene Capsules Targretin Temozolomide Temodal Mequinol 2%/Tretinoin 0.01% Solage Linezolid Zyvox Amphotericin B Liposome for Injection Ambisome Terbinafine HCl 1% Solution Lamisil

Update on Drugs and Drug News: February 2012

Update on drugs, approval dates, and comments. Adapalene 0.1% + benzoyl peroxide 2.5% gel (Epiduo®), Hyaluronic acid-based dermal filler (Belotero® Balance), Drospirenone 3 mg + ethinyl estradiol 0.02 mg (Vestura™) are covered.

Update on Drugs and Drug News – May 2008

Update on Triphendiol (formerly NV-196), Cyclic pentapeptide vascular-targeting agent ADH-1, Certolizumab pegol Cimzia® and drug news from around the world.

Update on Drugs and Drug News: January 2009

Update on Ceftobiprole (Zeftera®) Johnson & Johnson/ Basilea Pharmaceuticals, IV Iclaprim Arpida Ltd., HPV Vaccine (Gardasil®) Merck & Co., Alitretinoin (Toctino®) Basilea Pharmaceuticals, and Atazanavir sulfate (REYATAZ®) Bristol-Myers Squibb.

Update on Drugs and Drug News: September, 1997

Update on: Tazarotene Gel 0.05%, 0.1% Tazorac® topical gel Ketoconazole Shampoo 2% Nizoral® Fluticasone proprionate Cutivate® Cream 0.05% Amoxicillin/clavulanic acid Augmentin®Indinavir, Crixivan®Nelfinavir, Viracept®Ritonavir, Norvir®Saquinavir, Invirase® Acitretin Soriatane®, Neotigason®

POPULAR